Dr. Peter Donnelly

Peter Donnelly (CEO of BioBusinessNI)
...
Peter Donnelly (CEO of BioBusinessNI)Title - "Innovation of eHealth products and services - an all Ireland sector perspective"Content - Peter will present an overview of product innovation activities of BioBusinessNI and its member businesses.He will draw on the results of an all-island economic impact report commissioned by BioBusinessNI, under the BioMedIreland programme, which will include data on previous, current and planned R&D efforts and spends, as well as turnover associated with newly released products.This will provide some interesting analysis for the innovation, research, development and marketing of health technology and biotechnology products and services in Ireland over the coming years.Pen profile - Dr Peter Donnelly received his BEng and PhD degrees from the University of Ulster in 1989 and 1993 respectively.Over the last 15 years he has provided a software and technical role for a number of blue-chip companies, new start businesses and research organisations. In 1999, as a software consultant Dr Donnelly set up his own company (IQ Solutions).Since then he has delivered software solutions, medical regulatory and accreditation compliance advice and bio-signal processing and vital sign diagnostic algorithm expertise to medical device companies throughout the UK and Ireland.Dr Donnelly became a founding director in Bluescope Medical Technologies Ltd, a medical device manufacturer, developing innovative intelligent cardio-pulmonary monitoring devices primarily for the critical and high dependence units in hospitals. Dr Donnelly is involved with groups and networks promoting software quality, software engineering and computational medicine.Dr Donnelly has introduced a software framework for developing software in medical devices that has received worldwide acclaim and been presented at leading international conferences.He is Chair of the Medical Technology Excellence Network (Medi-TEN) in N. Ireland and Chief Executive of BioBusinessNI.

Dr Peter Donnelly, CEO of Bluescope Medical Technologies stated that: "It is extremely important in developing innovative medical devices that there is a clinical need and that the development is coupled and underpinned with advanced research. The support of Lisburn City Council has enabled the University of Ulster to lend a body of research and considerable knowledge to supporting Bluescope's technology platform and product portfolio and we can certainly see a long-term partnership developing."

Dr Peter Donnelly and Andy O'Hara founders of Bluescope Medical Technologies who were participants on the Innovation Promoters Programme 2008, pictured with Cllr Allan Ewart

Dr Peter Donnelly, CEO of Bluescope Medical Technologies stated that: "It is extremely important in developing innovative medical devices that there is a clinical need and that the development is coupled and underpinned with advanced research.

According to Peter Donnelly of Bio Business Northern Ireland, the Life and Technologies Sector in Northern Ireland employs over 4,000 people and has a turnover of £310 million.